Learn about a woman’s journey through ovarian cancer in a moving 3-part series by SHARE

Megaphone: Vol. 4, Iss. 5

SHARE recently published a 3-part series about ovarian cancer by Dramatic Health. The short videos follow Annie, a working mother who has been battling the disease for 9 years.

The videos serve to teach audiences about the services that SHARE provides for women like Annie who are dealing with the diagnosis and treatment of cancer.

 

 

Click here to watch episode 02.

Click here to watch episode 03.

Discover what eosinophilic granulomatosis with polyangiitis is with this real patient story

GSK used a real patient to explain what eosinophilic granulomatosis with polyangiitis (EGPA) is in a new video focusing on rare diseases. Learn what the disease is and what it can do to the body.  Watch now.

A Facebook Live event shines a light on sickle cell disease

Novartis is embracing new social technology to put on a Facebook Live event in which a panel consisting of an expert and two football players discuss and raise awareness of sickle cell disease.  Watch now.

Patients at a children’s hospital share a special thanks to their nurses

The adolescent patients of UCSF Medical Center’s children’s hospital gave a warm thank you to the nurses who care for them in honor of National Nurse’s Week.  Watch now.

Child feels “super” after a new 3D printed bionic arm

A new video by Oregon Health & Science University focuses on a clinical trial, which brings the power of 3D printers to cutting edge medical science. Watch as a child shares how a 3D printed arm has changed his life.  Watch now.

Active surveillance helps man live a surgery-free life

Learn why active surveillance can be as beneficial as surgical intervention in a new video by Johns Hopkins Medicine.  Watch now.

Featured Story

Sean Moloney of DHI spoke at the Digital Health Coalition East Coast Summit with special guest, Tricia Brown of Merck.


 

Read a snippet of their important panel. Click here.

Posted in Megaphone: Health Video Headlines, News

Leave a Reply

Your email address will not be published. Required fields are marked *